FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-12
DOI
10.1038/s41419-020-03282-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer
- (2020) Lu Yang et al. CELL DEATH AND DIFFERENTIATION
- BRCA1 mutations in cancer: coordinating deficiencies in homologous recombination with tumorigenesis
- (2020) John J. Krais et al. CANCER RESEARCH
- Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer
- (2020) Piotr Przanowski et al. CANCER RESEARCH
- Six2 mediates late-stage metastasis via direct regulation of Sox2 and induction of a cancer stem cell program
- (2019) Michael U.J. Oliphant et al. CANCER RESEARCH
- Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy
- (2019) Jiabei He et al. Cell Death & Disease
- The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression
- (2019) Ameer L. Elaimy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
- (2019) Andrew Sulaiman et al. Cancers
- Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
- (2019) Kha-Liang Lee et al. Cancers
- CD133 in Breast Cancer Cells: More than a Stem Cell Marker
- (2019) Federica Brugnoli et al. Journal of Oncology
- EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming
- (2019) Fanyan Meng et al. Nature Communications
- Harnessing DNA Double-Strand Break Repair for Cancer Treatment
- (2019) Anika Trenner et al. Frontiers in Oncology
- Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
- (2018) Yinghua Zhu et al. Nature Communications
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists
- (2018) Ping Yin et al. CANCER SCIENCE
- Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
- (2018) Jun Tian et al. BRITISH JOURNAL OF CANCER
- Dynamin impacts homology-directed repair and breast cancer response to chemotherapy
- (2018) Sophia B. Chernikova et al. JOURNAL OF CLINICAL INVESTIGATION
- Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
- (2018) Gaofeng Xiong et al. Nature Communications
- Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families
- (2017) Oksana Voloshanenko et al. FASEB JOURNAL
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Survivin: a unique target for tumor therapy
- (2016) Himani Garg et al. Cancer Cell International
- Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance
- (2016) Sana Ferroudj et al. HEPATOLOGY RESEARCH
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
- (2016) Zachary Steinhart et al. NATURE MEDICINE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- WNT5A: a motility-promoting factor in Hodgkin lymphoma
- (2016) F Linke et al. ONCOGENE
- Survivin contributes to DNA repair by homologous recombination in breast cancer cells
- (2015) Eloïse Véquaud et al. BREAST CANCER RESEARCH AND TREATMENT
- FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance
- (2015) Gabriela Nestal de Moraes et al. CELLULAR SIGNALLING
- Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways
- (2015) Sergej Skvortsov et al. SEMINARS IN CANCER BIOLOGY
- EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
- (2015) Tao Wang et al. Theranostics
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
- (2013) P Khongkow et al. ONCOGENE
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
- (2012) Yun-Yong Park et al. CARCINOGENESIS
- DNA Damage Repair Pathways in Cancer Stem Cells
- (2012) M. Maugeri-Sacca et al. MOLECULAR CANCER THERAPEUTICS
- The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
- (2012) L J Monteiro et al. ONCOGENE
- An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
- (2011) H E Lee et al. BRITISH JOURNAL OF CANCER
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- FZD7 has a critical role in cell proliferation in triple negative breast cancer
- (2011) L Yang et al. ONCOGENE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search